These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22511696)

  • 21. Simultaneous determination of carisoprodol and meprobamate in human hair using solid-phase extraction and gas chromatography/mass spectrometry of the trimethylsilyl derivatives.
    Kim JY; In MK; Paeng KJ; Chung BC
    Rapid Commun Mass Spectrom; 2005; 19(21):3056-62. PubMed ID: 16200657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impairment due to intake of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J
    Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mass spectrometric analysis of carisoprodol and meprobamate in rat brain microdialysates.
    Prokai L; Fryčák P; Nguyen V; Forster MJ
    J Mass Spectrom; 2016 Oct; 51(10):900-907. PubMed ID: 27747995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose carisoprodol during pregnancy and lactation.
    Briggs GG; Ambrose PJ; Nageotte MP; Padilla G
    Ann Pharmacother; 2008 Jun; 42(6):898-901. PubMed ID: 18460586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carisoprodol concentrations from different anatomical sites: three overdose cases.
    Backer RC; Zumwalt R; McFeeley P; Veasey S; Wohlenberg N
    J Anal Toxicol; 1990; 14(5):332-4. PubMed ID: 2263072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carisoprodol: an unrecognized drug of abuse.
    Bailey DN; Briggs JR
    Am J Clin Pathol; 2002 Mar; 117(3):396-400. PubMed ID: 11888078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP2C19 genetics in fatal carisoprodol intoxications.
    Høiseth G; Majid U; Mørland J; Bramness JG; Molden E
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1561-5. PubMed ID: 22527345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Quantitative determination of meprobamate and carisoprodol by gas chromatography in different cases of poisoning].
    Maes R; Bouche R; Laruelle L
    Eur J Toxicol; 1970; 3(2):140-3. PubMed ID: 5520468
    [No Abstract]   [Full Text] [Related]  

  • 29. Factors impacting variability of the urinary normeperidine-to-meperidine metabolic ratio in patients with chronic pain.
    Moy KV; Ma JD; Best BM; Atayee RS
    J Anal Toxicol; 2014; 38(1):1-7. PubMed ID: 24133175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carisoprodol, meprobamate, and driving impairment.
    Logan BK; Case GA; Gordon AM
    J Forensic Sci; 2000 May; 45(3):619-23. PubMed ID: 10855968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the first immunoassay for the semi-quantitative measurement of meprobamate in human whole blood or plasma using biochip array technology.
    Alvarez JC; Duverneuil C; Zouaoui K; Abe E; Charlier P; de la Grandmaison GL; Grassin-Delyle S
    Clin Chim Acta; 2012 Jan; 413(1-2):273-7. PubMed ID: 22057036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPLC MS/MS method for quantification of meprobamate in human plasma: application to 24/7 clinical toxicology.
    Delavenne X; Gay-Montchamp JP; Basset T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(2):215-8. PubMed ID: 21185792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carisoprodol (Soma): a new and cautious perspective on an old agent.
    Littrell RA; Hayes LR; Stillner V
    South Med J; 1993 Jul; 86(7):753-6. PubMed ID: 8322081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the frequency of carisoprodol withdrawal syndrome increasing?
    Reeves RR; Hammer JS; Pendarvis RO
    Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fixed drug eruption to carisoprodol and cross reaction with meprobamate.
    HONEYCUTT WM; CURTIS AC
    JAMA; 1962 May; 180():691-2. PubMed ID: 13908692
    [No Abstract]   [Full Text] [Related]  

  • 36. Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma.
    Jian W; Edom R; Weng N; Zannikos P; Zhang Z; Wang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1687-99. PubMed ID: 20462810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of traffic accidents after prescriptions of carisoprodol.
    Bramness JG; Skurtveit S; Mørland J; Engeland A
    Accid Anal Prev; 2007 Sep; 39(5):1050-5. PubMed ID: 17854578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variability in metabolism of imipramine and desipramine using urinary excretion data.
    Ramey K; Ma JD; Best BM; Atayee RS; Morello CM
    J Anal Toxicol; 2014; 38(6):368-74. PubMed ID: 24782142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of oral carisoprodol 250 and 350 mg and metabolism to meprobamate: A single-dose crossover study.
    Simon S; D'Andrea C; Wheeler WJ; Sacks H
    Curr Ther Res Clin Exp; 2010 Feb; 71(1):50-9. PubMed ID: 24683250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.